沃森生物：公司四价流脑结合疫苗目前处于III期临床研究阶段

Core Viewpoint - Watson Bio is currently in the III phase of clinical research for its quadrivalent meningococcal vaccine and is adhering to national drug registration procedures and regulations [1] Group 1 - Investors inquired about the completion of the review work for the III phase clinical summary report of the quadrivalent meningococcal vaccine [1] - The company confirmed that the quadrivalent meningococcal vaccine is still in the III phase of clinical research [1] - The company emphasized its commitment to following the relevant regulations for drug registration [1]